Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?

Udo Bonnet^{1

2}, Volker Auwärter³, Norbert Scherbaum²

Affiliations

¹ Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg-Essen, Castrop-Rauxel, Germany.
² LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
³ Department of Forensic Toxicology, Institute of Forensic Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Udo Bonnet et al. Lancet Reg Health Am. 2022.

. 2022 Jun 29:11:100309.

doi: 10.1016/j.lana.2022.100309. eCollection 2022 Jul.

Udo Bonnet^{1

2}, Volker Auwärter³, Norbert Scherbaum²

¹ Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg-Essen, Castrop-Rauxel, Germany.
² LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
³ Department of Forensic Toxicology, Institute of Forensic Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

No abstract available

Conflict of interest statement

The authors have no conflict of interest to declare.

1. Tardelli VS, Bianco MCM, Prakash R, et al. Overdose deaths involving non-BZD hypnotic/sedatives in the USA: trends analyses. Lancet Reg Health - Americas. 2022 [Epub ahead of print] - PMC - PubMed
1. Fonseca F, Lenahan W, Dart RC, et al. Non-medical use of prescription gabapentinoids (Gabapentin and Pregabalin) in five European countries. Front Psychiatry. 2021;12 - PMC - PubMed
1. Bonnet U, Specka M, Soyka M, et al. Ranking the harm of psychoactive drugs including prescription analgesics to users and others-a perspective of German addiction medicine experts. Front Psychiatry. 2020;11 - PMC - PubMed
1. Evoy KE, Sadrameli S, Contreras J, et al. Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs. 2021;81(1):125–156. - PubMed
1. Zhao D, Baek J, Hume AL, et al. Geographic variation in the use of gabapentinoids and opioids for pain in a commercially insured adult population in the United States. J Pain Res. 2022;15:443–454. - PMC - PubMed